Literature DB >> 19961985

In utero beta 2 adrenergic agonist exposure and adverse neurophysiologic and behavioral outcomes.

Frank R Witter1, Andrew W Zimmerman, James P Reichmann, Susan L Connors.   

Abstract

Beta 2 adrenergic receptor overstimulation during critical periods of prenatal development can induce a permanent shift in the balance of sympathetic-to-parasympathetic tone. This is a biologically plausible mechanism whereby beta 2 adrenergic agonists can induce functional and behavioral teratogenesis, which explains their association with increases in autism spectrum disorders, psychiatric disorders, poor cognitive, motor function and school performance, and changes in blood pressure in the offspring. The use of beta 2 adrenergic agonists should be limited to proven indications when alternate drugs are ineffective or unavailable; the risks of untreated disease to the mother and fetus are greater than the risk of the beta 2 adrenergic agonist.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19961985     DOI: 10.1016/j.ajog.2009.07.010

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  16 in total

1.  Terbutaline impairs the development of peripheral noradrenergic projections: potential implications for autism spectrum disorders and pharmacotherapy of preterm labor.

Authors:  Theodore A Slotkin; Frederic J Seidler
Journal:  Neurotoxicol Teratol       Date:  2012-07-16       Impact factor: 3.763

2.  Developmental neurotoxicity resulting from pharmacotherapy of preterm labor, modeled in vitro: Terbutaline and dexamethasone, separately and together.

Authors:  Theodore A Slotkin; Samantha Skavicus; Frederic J Seidler
Journal:  Toxicology       Date:  2018-03-07       Impact factor: 4.221

Review 3.  Effects of antenatal corticosteroids on the hypothalamic-pituitary-adrenocortical axis of the fetus and newborn: experimental findings and clinical considerations.

Authors:  Feizal Waffarn; Elysia Poggi Davis
Journal:  Am J Obstet Gynecol       Date:  2012-06-13       Impact factor: 8.661

4.  Prenatal drug exposures sensitize noradrenergic circuits to subsequent disruption by chlorpyrifos.

Authors:  Theodore A Slotkin; Samantha Skavicus; Frederic J Seidler
Journal:  Toxicology       Date:  2015-09-28       Impact factor: 4.221

5.  Prenatal exposure to β2-adrenergic receptor agonists and risk of autism spectrum disorders.

Authors:  Lisa A Croen; Susan L Connors; Marilyn Matevia; Yinge Qian; Craig Newschaffer; Andrew W Zimmerman
Journal:  J Neurodev Disord       Date:  2011-08-27       Impact factor: 4.025

Review 6.  Tocolysis: Present and future treatment options.

Authors:  Joshua D Younger; Elena Reitman; George Gallos
Journal:  Semin Perinatol       Date:  2017-12       Impact factor: 3.311

Review 7.  Are Attributes of Pregnancy and the Delivery Room Experience Related to Development of Autism? A Review of the Perinatal and Labor Risk Factors and Autism.

Authors:  Naveen Dhawan; Blaze Emerson; Romana Popara; Catherine Lin; Adam Rawji; Rita Zeiden; Leeda Rashid; Pwint Phyu; Jaya Bahl; Vineet Gupta
Journal:  Int Sch Res Notices       Date:  2014-10-01

8.  Benzo(a)pyrene triggers desensitization of β2-adrenergic pathway.

Authors:  Abdullah Mayati; Normand Podechard; Manuelle Rineau; Lydie Sparfel; Dominique Lagadic-Gossmann; Olivier Fardel; Eric Le Ferrec
Journal:  Sci Rep       Date:  2017-06-12       Impact factor: 4.379

Review 9.  Environmental factors influencing the risk of autism.

Authors:  Padideh Karimi; Elahe Kamali; Seyyed Mohammad Mousavi; Mojgan Karahmadi
Journal:  J Res Med Sci       Date:  2017-02-16       Impact factor: 1.852

10.  Environmental risk factors for autism.

Authors:  Rodney R Dietert; Janice M Dietert; Jamie C Dewitt
Journal:  Emerg Health Threats J       Date:  2011-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.